FINANCIAL CONSULATE, INC – Bristol-Myers Squibb Company Transaction History
FINANCIAL CONSULATE, INC portfolio value:
$225,000
portfolio value
FINANCIAL CONSULATE, INC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | -18K | $71.09 | 3.16K | |
Q2 2022 | share | 0.00% | 0 shares | 12K | $77 | 3.16K | |
Q1 2022 | share | Increase | 0.00% | 3.16K shares | 231K | $73.03 | 3.16K |
Q3 2021 | share | Decrease | -100.00% | -3.16K shares | -211K | $59.17 | 0 |
Q2 2021 | share | Decrease | -5.24% | -175 shares | 0 | $65.79 | 3.16K |
Q1 2021 | share | 0.00% | 0 shares | 4K | $62.15 | 3.33K | |
Q4 2020 | share | Increase | +0.75% | 25 shares | 7K | $60.6 | 3.33K |
Q3 2020 | share | Decrease | -9.43% | -345 shares | -15K | $58 | 3.31K |
Q2 2020 | share | Decrease | -3.31% | -125 shares | 4K | $56.14 | 3.65K |
Q1 2020 | share | Decrease | -0.47% | -18 shares | -33K | $52.79 | 3.78K |
Q4 2019 | share | Increase | 0.00% | 3.8K shares | 244K | $60.36 | 3.8K |